Cartilax

Cartilax belongs to a class of preparations called peptide bioregulators — short peptide complexes extracted from a specific animal tissue, developed and studied primarily in Russian gerontology institutes over several decades. Each member of the class is named for and derived from the tissue it came from; Cartilax is the cartilage-derived one.

These are not receptor agonists in the conventional sense, and the literature does not describe them as such. The mechanism proposed and tested is interaction with DNA and regulation of tissue-specific gene expression, which is why the research reads quite differently from that of a signalling peptide.

The organising idea of the whole bioregulator field is that a peptide fragment obtained from a given tissue shows affinity for that same tissue. Work on Cartilax examines that claim in cartilage:

• Chondrocyte activity and viability in culture

• Extracellular matrix composition, particularly proteoglycan and collagen II content

• Gene expression profiles in cartilage tissue under experimental load or degradation

• Age-related changes in cartilage, the original framing of the bioregulator programme

Most of the foundational bioregulator research was published in Russian, in journals with limited international indexing, and replication outside those institutes remains thin. That is a material caveat rather than a dismissal, and researchers selecting these compounds are generally doing so with the provenance of the evidence explicitly in view.

Epithalon and Pinealon are the pineal-derived and brain-derived members of the same family, and are the natural comparators when the question is about the class rather than about cartilage. For connective tissue through an unrelated mechanism, see BPC-157.